• Lenzing swung to adjusted earnings after tax of EUR 42.4 million in the first nine months of 2026.
• Adjusted EBITDA rose to EUR 353 million, while the adjusted EBITDA margin increased to 18.3%.
• Production at Heiligenkreuz is scheduled to cease by end-Q1 2027, while Grimsby production will end by the close of 2027.
• Full-year 2026 adjusted EBITDA is expected to rise to between EUR 430 million and EUR 460 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lenzing AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2428804_en) on November 05, 2026, and is solely responsible for the information contained therein.